Diabetes Technology Research Group Director Professor David O’Neal discusses the work being done on the Flash Study run at this site by our coordinator Lesley Robinson

St Vincent’s Hospital Melbourne (SVHM) and the DTRG taking part in a national multi-centre study aiming to make glucose testing easier and more accessible for First Nations patients with Type 2 diabetes; the FLASH GM Study.

The study is investigating a wearable monitoring device’s ability to improve patients’ sugar levels in the place of traditional finger-prick testing.

Professor David O’Neal, a Senior Endocrinologist at SVHM and one of the study’s Chief Investigators, said this is particularly important research for a vulnerable group known to have a high incidence of Type 2 diabetes.

These devices have been proven to help monitor and maintain glucose levels in people with Type 2 in the general population. However, Prof O’Neal said there is a gap in the evidence.

“We don’t have the data for our Indigenous population, who we propose could potentially benefit substantially from using this technology,” said Prof O’Neal.

To read more, visit the St Vincent’s Newsroom: https://lnkd.in/gF8ZskmN

Share this post

Diabetes Technology Research Group Director Professor David O’Neal discusses the work being done on the Flash Study run at this site by our coordinator Lesley Robinson

St Vincent’s Hospital Melbourne (SVHM) and the DTRG taking part in a national multi-centre study aiming to make glucose testing easier and more accessible for First Nations patients with Type 2 diabetes; the FLASH GM Study.

The study is investigating a wearable monitoring device’s ability to improve patients’ sugar levels in the place of traditional finger-prick testing.

Professor David O’Neal, a Senior Endocrinologist at SVHM and one of the study’s Chief Investigators, said this is particularly important research for a vulnerable group known to have a high incidence of Type 2 diabetes.

These devices have been proven to help monitor and maintain glucose levels in people with Type 2 in the general population. However, Prof O’Neal said there is a gap in the evidence.

“We don’t have the data for our Indigenous population, who we propose could potentially benefit substantially from using this technology,” said Prof O’Neal.

To read more, visit the St Vincent’s Newsroom: https://lnkd.in/gF8ZskmN

Share this post